Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Sicriptin 1.25 Tablet

Prescription Icon
Prescription Required

Marketer

Serum Institute Of India Ltd

Salt Composition

Bromocriptine (1.25mg)

Overview Sicriptin 1.25 Tablet

Cabergoline 1.25mg tablets effectively manage elevated prolactin levels, aiding in the treatment of female infertility and acromegaly. Its mechanism involves suppressing prolactin (the milk-producing hormone) secretion. In acromegaly, it additionally reduces growth hormone production. For optimal absorption, consume Cabergoline 1.25mg with food, maintaining a consistent daily schedule. Dosage and frequency are determined by your physician based on your specific condition and response to treatment. Continue taking the medication as prescribed. Maintain a healthy lifestyle including regular exercise and a balanced diet; if you have diabetes, continue taking your prescribed diabetes medication. Common side effects may include nausea, vomiting, headache, tiredness, and dizziness. Report any persistent or severe side effects to your doctor; management strategies are available. Always carry glucose tablets to counter potential hypoglycemia. Alcohol consumption should be avoided due to the risk of intensified side effects. Before starting treatment, inform your doctor of any pre-existing liver or kidney conditions, and disclose all other medications you are currently using, as interactions are possible. Also, inform your doctor if you are pregnant or breastfeeding.

Primary Ingredients of Sicriptin 1.25 Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Sicriptin 1.25 Tablet

Elevated prolactin, leading to infertility in women, and acromegaly.

Major Benefits of Sicriptin 1.25 Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take the Sicriptin 1.25mg tablet with food.

Common Side effects of Sicriptin 1.25 Tablet:

  • Nausea
  • Headache
  • Dizziness
  • Fatigue
  • Constipation
  • Inflammation of the nose
  • Weakness

How to use Sicriptin 1.25 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Sicriptin 1.25 Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Sicriptin 1.25 Tablet works:

Bromocriptine 1.25mg tablets function as a dopamine receptor stimulant, effectively curbing prolactin secretion. Elevated prolactin, the milk-producing hormone, is linked to inappropriate lactation and suppressed reproductive function, potentially leading to infertility. Consequently, Bromocriptine 1.25mg tablets can alleviate these issues by normalizing prolactin levels. Furthermore, in acromegalic patients, this medication reduces growth hormone production.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sicriptin 1.25 Tablet and alcohol is contraindicated.

PregnancyPregnancySAFE IF PRESCRIBED

Pregnancy use of Sicriptin 1.25 Tablet is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Sicriptin 1.25 Tablet while breastfeeding is likely inadvisable. Available evidence indicates potential transfer to breast milk, posing a risk to the infant. Its use during lactation is generally avoided due to its lactation-suppressing effect.

DrivingDrivingCAUTION

Taking a 1.25 mg Sicriptin tablet can sometimes lead to lightheadedness or fatigue from lowered blood pressure. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

The use of Sicriptin 1.25 mg tablets in patients with kidney impairment is likely safe. Existing evidence indicates dose modification may not be necessary, however, physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Sicriptin 1.25 Tablet use in individuals with hepatic impairment. Medical advice is recommended. Nevertheless, its administration to such patients should be approached with prudence.

What if you forget to take Sicriptin 1.25 Tablet :

NA

Facts to Know About Sicriptin 1.25 Tablet

LabelValue
Chemical Category Ergoline alkaloids
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Action Class Elevated Prolactin from Dopamine Agonists

FAQs on Sicriptin 1.25 Tablet

Hyperprolactinemia is characterized by abnormally high blood levels of prolactin, a hormone from the pituitary gland. In women, prolactin controls menstruation and milk production. Elevated prolactin lowers estrogen, disrupting ovulation, resulting in irregular or absent periods and fertility problems. It also causes decreased bone density and spontaneous breast milk production. High prolactin levels also impact testosterone levels.
High prolactin levels are detectable via blood test. Borderline results may warrant repeat testing. Further evaluation might include a physical examination and brain MRI.
Prolactin levels typically range as follows: Men: below 20 ng/mL (425 µg/L); Non-pregnant women: below 25 ng/mL (25 µg/L); Pregnant women: 80–400 ng/mL (80–400 µg/L).
Hyperprolactinemia sometimes has an unidentified cause. Other causes include pituitary gland tumors (noncancerous), pituitary gland overactivity, hypothyroidism, some medications, and stress.
High prolactin levels can induce lactation in non-pregnant, non-lactating women and men. Women may also experience menstrual irregularities and infertility, while men might encounter decreased libido and erectile dysfunction.
Sicriptin 1.25 Tablet reduces elevated prolactin levels, potentially aiding ovulation and increasing the chance of pregnancy. Success, however, also depends on factors such as age, intercourse timing and frequency, underlying health conditions, and egg and sperm quality. Consult your physician with any questions.
Elevated prolactin hinders follicle-stimulating hormone (FSH) release, suppressing ovulation. Consequently, breastfeeding mothers, with their naturally high prolactin levels, typically experience lactational amenorrhea, preventing pregnancy.
Sicriptin 1.25 Tablets don't enhance fertility directly; they lower elevated prolactin levels, potentially restoring normal ovulation or improving responses to fertility medications.
Sicriptin 1.25 Tablets lower blood pressure in hypertensive patients, potentially causing dizziness or lightheadedness upon standing, and possibly fainting if you already have low blood pressure.
Concurrent use of Sicriptin 1.25 Tablet and other blood pressure medications may result in excessively low blood pressure and dizziness. Consult your physician if you have any concerns.
Avoid combining Sicriptin 1.25 Tablet with alcohol. This combination may worsen side effects and, in women, interfere with ovulation, hindering conception. Alcohol can also negatively impact male fertility by affecting sperm.
Sicriptin 1.25 Tablet
118
MRP 136
13% off